Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers

Proteomics - Clinical Applications

Volumn 2, Issue 2, 2008, Pages 158-166

  Nelsestuen, Gary L ^a,e   Harvey, Stephen B ^a   Zhang, Yan ^a   Kasthuri, Raj S ^b   Sinaiko, Alan R ^b   Ely, E Wesley ^c   Bernard, Gordon R ^c   Homoncik, Monika ^d   Jilma, Bernd ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e NONE   (United States)

Author keywords

Human; Mass spectra; Plasma

Indexed keywords

ANTIBODY; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; BIOLOGICAL MARKER; ISOPROTEIN; PEPTIDE; THIOL DERIVATIVE;

AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; CARBOXY TERMINAL SEQUENCE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; ENZYME POLYMORPHISM; HOMEOSTASIS; HUMAN; IMMUNOASSAY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OBESITY; OXIDATION REDUCTION REACTION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SENSITIVITY ANALYSIS; STRUCTURAL PROTEOMICS;

EID: 39649087127     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780107     Document Type: Review

References (46)

1. Anderson, N. L., Anderson, N. G., The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
2. Anderson, N. L., The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol. Cell. Proteomics 2005, 4, 1441-1444.
3. Zolg, W., The proteomic search for diagnostic biomarkers: Lost in translation? Mol. Cell. Proteomics 2006, 5, 1720-1726.
4. Washburn, M. P., Utilisation of proteomics datasets generated via multidimensional protein identification technology (MudPIT). Brief. Funct. Genomic. Proteomic. 2004, 3, 280-286.
5. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
6. Diamandis, E. P., Proteomic patterns in serum and identification of ovarian cancer. Lancet 2002, 360, 170, author reply 170-171.
7. Aristoteli, L. P., Molloy, M. P., Baker, M. S., Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. J. Proteome Res. 2007, 6, 571-581.
8. Villanueva, J., Shaffer, D. R., Philip, J., Chaparro, C. A. et al., Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest, 2006, 116, 271-284.
9. Baggerly, K. A., Morris, J. S., Coombes, K. R., Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioinformatics 2004, 20, 777-785.
10. Baggerly, K. A., Morris, J. S., Edmonson, S. R., Coombes, K. R., Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 2005, 97, 307-309.
11. Villanueva, J., Philip, J., Chaparro, C. A., Li, Y. et al., Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4, 1060-1072.
12. Allard, L., Lescuyer, P., Burgess, J., Leung, K. Y. et al., ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 2004, 4, 2242-2251.
13. Malik, G., Ward, M. D., Gupta, S. K., Trosset, M. W. et al., Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin. Cancer Res. 2005, 11, 1073-1085.
14. Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K. et al., Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005, 5, 4589-4596.
15. Engwegen, J. Y., Helgason, H. H., Cats, A., Harris, N. et al., Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J. Gastroenterol. 2006, 12, 1536-1544.
16. Freeman, W. M., Gooch, R. S., Lull, M. E., Worst, T. J. et al., Apo-All is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol Alcohol. 2006, 41, 300-305.
17. Sundsten, T., Zethelius, B., Berne, C., Bergsten, P., Plasma proteome changes in type 2 diabetes mellitus subjects with low or high early insulin response. Clin. Sci. (Lond.) 2007. Epub ahead of print, doi: 10.1042/CS20070323
18. Hegedus, C. M., Skibola, C. F., Bracci, P., Holly, E. A., Smith, M. T., Screening the human serum proteome for genotype-phenotype associations: An analysis of the IL6-174G>C polymorphism. Proteomics 2007, 7, 548-557.
19. Beretta, L., Proteomics from the clinical perspective: Many hopes and much debate. Nat. Methods 2007, 4, 785-786.
20. Nelsestuen, G. L., Enhancement of vitamin-K-dependent protein function by modification of the gamma-carboxyglutamic acid domain: Studies of protein C and factor VII. Trends Cardiovasc. Med. 1999, 9, 162-167.
21. Harvey, S. B., Stone, M. D., Martinez, M. B., Nelsestuen, G. L., Mutagenesis of the gamma-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact site. J. Biol. Chem. 2003, 278, 8363-8369.
22. Lacey, J. M., Bergen, H. R., Magera, M. J., Naylor, S., O'Brien, J. F., Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin. Chem. 2001, 47, 513-518.
23. Bergen, H. R., Lacey, J. M., O'Brien, J. F., Naylor, S., Online single-step analysis of blood proteins: The transferrin story. Anal. Biochem. 2001, 296, 122-129.
24. Bergen, H. R., III, Zeldenrust, S. R., Butz, M. L., Snow, D. S. et al., Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin. Chem. 2004, 50, 1544-1552.
25. Bergen, H. R., III, Zeldenrust, S. R., Naylor, S., An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum. Amyloid 2003, 10, 190-197.
26. Bar-Or, D., Heyborne, K. D., Bar-Or, R., Rael, L. T. et al., Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn 2005, 25, 245-249.
27. Fung, E. T., Yip, T. T., Lomas, L., Wang, Z. et al., Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int. J. Cancer 2005, 115, 783-789.
28. Nelsestuen, G. L., Zhang, Y., Martinez, M. B., Key, N. S., et al., Plasma protein profiling: Unique and stable features of individuals. Proteomics 2005, 5, 4012-4024.
29. Sen, J. W., Bergen, H. R., III, Heegaard, N. H., On-line immunoaffinity-liquid chromatography-mass spectrometry for identification of amyloid disease markers in biological fluids. Anal. Chem. 2003, 75, 1196-1202.
30. Bondarenko, P. V., Cockrill, S. L., Watkins, L. K., Cruzado, I. D., Macfarlane, R. D., Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J. Lipid Res. 1999, 40, 843-555.
31. Jin, Y., Manabe, T., Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry. Electrophoresis 2005, 26, 2823-2834.
32. Wroblewski, M. S., Wilson-Grady, J. T., Martinez, M. B., Kasthuri, R. S. et al., A functional polymorphism of apolipoprotein C1 detected by mass spectrometry. FEBS J. 2006, 273, 4707-4715.
33. Kasthuri, R. S., McMillan, K. R., Flood-Urdangarin, C., Harvey, S. B. et al., Correlation of a T45S variant of apolipoprotein C1 with elevated BMI in persons of American Indian and Mexican ancestries. Int. J. Obes. (Lond.) 2007, 31, 1334-1336.
34. Buchko, G. W., Rozek, A., Hoyt, D. W., Cushley, R. J., Kennedy, M. A., The use of sodium dodecyl sulfate to model the apolipoprotein environment. Evidence for peptide-SDS complexes using pulsed-field-gradient NMR spectroscopy. Biochim. Biophys. Acta 1998, 1392, 101-108.
35. Kasthuri, R. S., Wroblewski, M., Jilma, B., Key, N. S., Nelsestuen, G. L., Potential biomarkers of an exaggerated response to endotoxemia. Biomarkers 2007, 12, 287-302.
36. Stein, P. E., Carrell, R. W., What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol. 1995, 2, 96-113.
37. von Eckardstein, A., Holz, H., Sandkamp, M., Weng, W. et al., Apolipoprotein C-III(Lys58 - Glu). Identification of an apolipoprotein C-III variant in a family with hyper-alphalipoproteinemia, J. Clin. Invest. 1991, 87, 1724-1731.
38. Lim, A., Sengupta, S., McComb, M. E., Theberge, R. et al., In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J. Biol. Chem. 2003, 278, 49707-49713.
39. Kiernan, U. A., Tubbs, K. A., Nedelkov, D., Niederkofler, E. E., Nelson, R. W., Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Lett. 2003, 537, 166-170.
40. Nelsestuen, G. L., Martinez, M. B., Hertz, M. I., Savik, K., Wendt, C. H., Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 2005, 5, 1706-1713.
41. Mauger, J. F., Couture, P., Bergeron, N., Lamarche, B., Apolipoprotein C-III isoforms: Kinetics and relative implication in lipid metabolism. J. Lipid Res. 2006, 47, 1212-1218.
42. Wopereis, S., Grunewald, S., Huijben, K. M., Morava, E. et al., Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects. Clin. Chem. 2007, 53, 180-187.
43. Kasthuri, R. S., Verneris, M. R., Ibrahim, H. N., Jilma, B., Nelsestuen, G. L., Studying multiple protein profiles over time to assess biomarker validity. Expert Rev. Proteomics 2006, 3, 456-464.
44. Lambeir, A. M., Durinx, C., Scharpe, S., Meester, I. De, Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 2003, 40, 209-294.
45. Rozek, A., Sparrow, J. T., Weisgraber, K. H., Cushley, R. J., Sequence-specific 1H NMR resonance assignments and secondary structure of human apolipoprotein C-I in the presence of sodium dodecyl sulfate. Biochem. Cell Biol. 1998, 76, 267-275.
46. Idris, I., Donnelly, R., Dipeptidyl peptidase-IV inhibitors: A major new class of oral antidiabetic drug. Diabetes Obes. Metab. 2007, 9, 153-165.